Róbert Kiss

Semmelweis University — Hungary

Medicine · Health Sciences

24h-index1.6kcitations82works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hormonal Regulation and Hypertension(16), Receptor Mechanisms and Signaling(15), Computational Drug Discovery Methods(11), Chemical Synthesis and Analysis(8), Adrenal Hormones and Disorders(8)

Publications82 total

Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial
Nature Medicine·2025· 3 cited
Author response for "A data-driven journey using results from target-based drug discovery for target deconvolution in phenotypic screening"
2025
Abstract 4143980: Bleeding with the FXI Inhibitor Abelacimab compared with Rivaroxaban in Patients on Antiplatelet therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial
Circulation·2024· 1 cited
DIY Virtual Chemical Libraries - Novel Starting Points for Drug Discovery
ACS Medicinal Chemistry Letters·2023· 3 citedOpen Access
Analysis of the uncharted, druglike property space by self-organizing maps
Molecular Diversity·2021· 10 citedOpen Access
DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits
Neurobiology of Disease·2019· 19 citedOpen Access
Comparative Physicochemical and Biological Characterisation of the Similar Biological Medicinal Product Teriparatide and Its Reference Medicinal Product
BioDrugs·2019· 12 citedOpen Access
Structural Basis of Small Molecule Targetability of Monomeric Tau Protein
ACS Chemical Neuroscience·2018· 31 cited
Szteroid-21-hidroxiláz-deficientia, a congenitalis adrenalis hyperplasia leggyakoribb oka
Orvosi Hetilap·2018· 2 citedOpen Access
Untitled
Honvédorvos·2018Open Access
Structural features of human DJ-1 in distinct Cys106 oxidative states and their relevance to its loss of function in disease
Biochimica et Biophysica Acta (BBA) - General Subjects·2017· 47 citedOpen Access
What NMR can do in the biopharmaceutical industry
Journal of Pharmaceutical and Biomedical Analysis·2017· 33 citedOpen Access
Identification of 8‐Hydroxyquinoline Derivatives Active Against Somatic V658F Mutant JAK1‐Dependent Cells
Archiv der Pharmazie·2016· 6 cited
Gláz Edit professzor asszony 90 éves!
Orvosi Hetilap·2016
Structure-based discovery and binding site analysis of histamine receptor ligands
Expert Opinion on Drug Discovery·2016· 12 cited
Structure-Based Consensus Scoring Scheme for Selecting Class A Aminergic GPCR Fragments
Journal of Chemical Information and Modeling·2016· 19 cited
新規のシリル‐およびトリチル‐修飾ヌクレオシドの合成とin vitro増殖阻害活性
Bioorganic & Medicinal Chemistry·2016
癌細胞に対するIrciniid属海綿動物由来の天然産物のin vitro増殖阻害活性:比較研究
BioMed Research International (Web)·2016
Cover Picture: Phenylalanine Ammonia‐Lyase‐Catalyzed Deamination of an Acyclic Amino Acid: Enzyme Mechanistic Studies Aided by a Novel Microreactor Filled with Magnetic Nanoparticles (ChemBioChem 16/2015)
ChemBioChem·2015· 1 citedOpen Access
Phenylalanine Ammonia‐Lyase‐Catalyzed Deamination of an Acyclic Amino Acid: Enzyme Mechanistic Studies Aided by a Novel Microreactor Filled with Magnetic Nanoparticles
ChemBioChem·2015· 58 cited
page 1 of 5Next →

Frequent Co-authors

György M. Keserű(20), Edit Gláz(9), K. Rácz(8), Peter P. Sayeski(5), Ivan Varga(5), Márk Sándor(4), Béla Kiss(3), S. Vida(3), Balázs Jójárt(3), Katalin Solti(3), Gergely Tóth(3), Dániel Erös(3), Tímea Polgár(3), Kirpal S. Bisht(3), Ibolya Varga(3), Kàroly Rácz(3), Orlin Sergev(3), László Őrfi(3), E Gláz(3), László Fütő(3)